|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,413,000 |
Market
Cap: |
9.12(B) |
Last
Volume: |
620,367 |
Avg
Vol: |
504,506 |
52
Week Range: |
$114.17 - $208.42 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$238,260 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
40,296 |
45,669 |
50,307 |
151,828 |
Total Sell Value |
$7,357,263 |
$8,416,817 |
$9,119,818 |
$30,980,273 |
Total People Sold |
2 |
4 |
5 |
6 |
Total Sell Transactions |
3 |
5 |
7 |
17 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cooper Glenn L Md |
Director |
|
2015-11-09 |
4 |
A |
$26.56 |
$26,564 |
D/D |
1,000 |
35,331 |
|
- |
|
Snodgres Jon |
Chief Financial Officer |
|
2015-07-14 |
4 |
D |
$41.30 |
$13,423 |
D/D |
(325) |
10,620 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2015-06-12 |
4 |
D |
$38.46 |
$62,498 |
D/D |
(1,625) |
43,642 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2015-06-09 |
4 |
S |
$37.48 |
$288,486 |
D/D |
(7,697) |
11,554 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2015-06-08 |
4 |
S |
$38.32 |
$1,046,368 |
D/D |
(27,303) |
19,251 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2015-05-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
20,331 |
|
- |
|
Goldberg Alfred Lewis |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
40,331 |
|
- |
|
Cox John |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,858 |
1,858 |
|
- |
|
Dawes Karen A |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,498 |
39,241 |
|
- |
|
Barthelemy Nicholas |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
1,019 |
|
- |
|
Cooper Glenn L Md |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
34,331 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
21,331 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2015-05-15 |
4 |
S |
$41.32 |
$619,833 |
D/D |
(15,000) |
96,849 |
|
- |
|
Herlihy Walter C |
PRESIDENT, CEO |
|
2015-05-12 |
4 |
S |
$38.97 |
$1,770,332 |
D/D |
(45,431) |
262,430 |
|
- |
|
Herlihy Walter C |
PRESIDENT, CEO |
|
2015-05-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
307,861 |
|
- |
|
Herlihy Walter C |
PRESIDENT, CEO |
|
2015-05-11 |
4 |
S |
$38.68 |
$1,381,610 |
D/D |
(35,715) |
317,861 |
|
- |
|
Herlihy Walter C |
PRESIDENT, CEO |
|
2015-05-08 |
4 |
S |
$37.55 |
$2,585,468 |
D/D |
(68,854) |
353,576 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2015-05-08 |
4 |
S |
$37.19 |
$743,800 |
D/D |
(20,000) |
20,312 |
|
- |
|
Herlihy Walter C |
PRESIDENT AND CEO |
|
2015-03-23 |
4 |
S |
$31.76 |
$752,173 |
D/D |
(23,686) |
422,430 |
|
- |
|
Herlihy Walter C |
PRESIDENT AND CEO |
|
2015-03-20 |
4 |
S |
$32.51 |
$27,629 |
D/D |
(850) |
446,116 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2015-03-19 |
4 |
S |
$33.30 |
$487,845 |
D/D |
(14,650) |
111,849 |
|
- |
|
Herlihy Walter C |
PRESIDENT AND CEO |
|
2015-03-19 |
4 |
S |
$33.08 |
$1,643,762 |
D/D |
(49,695) |
446,966 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2015-03-19 |
4 |
S |
$32.62 |
$326,187 |
D/D |
(10,000) |
40,312 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2015-03-18 |
4 |
S |
$32.63 |
$515,443 |
D/D |
(15,795) |
46,554 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2015-03-18 |
4 |
OE |
$6.23 |
$122,869 |
D/D |
13,807 |
62,349 |
|
- |
|
464 Records found
|
|
Page 17 of 19 |
|
|